Premium
5‐Lipoxygenase m RNA and Protein Isoforms
Author(s) -
Ochs Meike J.,
Suess Beatrix,
Steinhilber Dieter
Publication year - 2014
Publication title -
basic and clinical pharmacology and toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.805
H-Index - 90
eISSN - 1742-7843
pISSN - 1742-7835
DOI - 10.1111/bcpt.12115
Subject(s) - gene isoform , arachidonate 5 lipoxygenase , lipoxygenase , arachidonic acid , lipid signaling , splice , alternative splicing , inflammation , leukotriene , rna , biochemistry , chemistry , biology , asthma , enzyme , immunology , gene
5‐Lipoxygenase (5‐ LO ) catalyses the two initial steps in the biosynthesis of leukotrienes, a group of inflammatory lipid mediators derived from arachidonic acid. An increased level of leukotrienes is associated with chronic inflammatory diseases such as asthma or atherosclerosis. In this M ini R eview, we focus on recent findings regarding alternative splice variants of 5‐ LO with a special emphasis on two potential protein isoforms expressed in human B ‐lymphocytes which might be of interest as new drug targets.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom